Literature DB >> 3538938

[Glucose-potassium-insulin in hypodynamic septic shock].

W Mauritz, I Schindler, E Zadrobilek, P Sporn.   

Abstract

Haemodynamic and metabolic effects of glucose-potassium-insulin (GKI) were studied in 14 patients with peritonitis. Study entry criteria were: hypodynamic septic shock (mean arterial pressure less than 50 mmHg and cardiac index less than 3.5 l/min) despite a highly positive fluid balance (greater than +2,000 ml during the last 12 h) and use of catecholamines (greater than 15 mcg/kg/min Dobutamine). GKI (glucose 70% 1 g/kg + potassium 10 mval + insulin 1.5 U/kg) was infused within 15 min via a central venous catheter. Before and 10 min after GKI haemodynamic and metabolic measurements were performed. GKI led to significant increases in systolic (+53%) and mean (+61%) arterial pressures, cardiac index (+50%), right (+60%) and left (+109%) ventricular stroke work indices, and oxygen consumption index (+18%). Heart rate remained unchanged, pulmonary shunt fraction increased slightly, systemic and pulmonary vascular resistances showed an insignificant decline. Serum glucose (p less than 0.01) and pCO2 (p less than 0.1) increased. The haemodynamic improvement lasted from 30 min or less (n = 3; 21%) to several hours. Nine patients (64%) survived more than 2 days, and two patients (14%) were eventually discharged from the hospital. We conclude, that in hypodynamic septic shock refractory to volume loading and catecholamine treatment GKI may be beneficial, although the mechanism of action remains unclear.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3538938

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  3 in total

1.  Glucose-insulin-potassium correlates with hemodynamic improvement in patients with septic myocardial dysfunction.

Authors:  Won-Young Kim; Moon Seong Baek; Young Shin Kim; Jarim Seo; Jin Won Huh; Chae-Man Lim; Younsuck Koh; Sang-Bum Hong
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 2.  Effect of glucose-insulin-potassium infusion on mortality in critical care settings: a systematic review and meta-analysis.

Authors:  Michael A Puskarich; Michael S Runyon; Stephen Trzeciak; Jeffrey A Kline; Alan E Jones
Journal:  J Clin Pharmacol       Date:  2009-05-05       Impact factor: 3.126

3.  Glucose-insulin-potassium infusion in sepsis and septic shock: no hard evidence yet.

Authors:  Iwan C C van der Horst; Jack J M Ligtenberg; Henk J G Bilo; Felix Zijlstra; Rijk O B Gans
Journal:  Crit Care       Date:  2002-10-09       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.